This compound is a critical chiral pharmaceutical intermediate primarily used in the synthesis of Saxagliptin, a key drug for type 2 diabetes mellitus. As a high-purity bicyclic building block, it features a unique azabicyclo[3.1.0]hexane core with defined stereochemistry, enabling precise construction of Saxagliptin’s active site. It undergoes deprotection and coupling reactions to form the final API, directly impacting drug yield and quality. Beyond diabetes treatment, it serves as a versatile chiral synthon for developing other dipeptidyl peptidase 4 (DPP-4) inhibitors and related therapeutic agents. Its rigid cyclic structure and chiral purity make it valuable for researching structure-activity relationships (SAR) in medicinal chemistry. Additionally, it is employed in academic and industrial laboratories as a reference standard for chiral analysis and method validation, supporting quality control in pharmaceutical manufacturing.

This substance is labeled GHS07 (Warning) with hazard statements H302 (Harmful if swallowed), H315 (Causes skin irritation), H319 (Causes serious eye irritation), and H335 (May cause respiratory irritation). Avoid inhalation of dust or mist; handle in a well-ventilated area with local exhaust and wear a dust respirator. Wear nitrile gloves, safety goggles, and protective clothing to prevent skin and eye contact. In case of skin contact, wash immediately with plenty of soap and water; for eye contact, rinse with running water for at least 15 minutes and seek medical attention if irritation persists. If swallowed, do not induce vomiting; seek medical advice promptly. Store separately from oxidizing agents, strong acids, and foodstuff; keep containers tightly closed in a cool, dry place. Spills should be collected with inert materials (sand, earth) and disposed of as hazardous waste; prevent entry into drains or waterways to avoid environmental harm.